MediWound (MDWD) Current Deferred Revenue (2015 - 2022)
MediWound (MDWD) posted Current Deferred Revenue of $31000.0 for Q3 2022, down 49.18% on a QoQ basis from $61000.0 in Q2 2022, and down 91.19% year-over-year from $352000.0 in Q3 2021.
Analysis
MediWound (MDWD) Current Deferred Revenue (2015 - 2022) Analysis & Trends
MediWound has reported Current Deferred Revenue for 8 years, with the latest figure at $31000.0 in Q3 2022.
- On a quarterly basis, Current Deferred Revenue fell 91.19% year-over-year to $31000.0 in Q3 2022; TTM through Sep 2022 was $31000.0, a 91.19% decrease from a year earlier, with the FY2021 full-year figure at $119000.0, down 90.36% from the prior year.
- Current Deferred Revenue was $31000.0 for Q3 2022 at MediWound, down from $61000.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $1.3 million in Q1 2018, with the low at $31000.0 in Q3 2022.
- Average Current Deferred Revenue over 5 years is $835421.1, with a median of $1.1 million recorded in 2019.
- The sharpest annual moves came in 2018 and 2022: Current Deferred Revenue jumped 35.58% in 2018, then tumbled 91.19% in 2022.
- Over 5 years, Current Deferred Revenue stood at $1.2 million in 2018, then slipped by 1.99% to $1.1 million in 2019, then grew by 8.72% to $1.2 million in 2020, then tumbled by 90.36% to $119000.0 in 2021, then sank by 73.95% to $31000.0 in 2022.
- The last three Current Deferred Revenue figures came in at $31000.0 (Q3 2022), $61000.0 (Q2 2022), and $91000.0 (Q1 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | MediWound | 156.09 Mn | 120.75 Mn | 337,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 31,000.00 |
| Jun 30, 2022 | 61,000.00 |
| Mar 31, 2022 | 91,000.00 |
| Dec 31, 2021 | 119,000.00 |
| Sep 30, 2021 | 352,000.00 |
| Jun 30, 2021 | 405,000.00 |
| Mar 31, 2021 | 693,000.00 |
| Dec 31, 2020 | 1.23 Mn |
| Sep 30, 2020 | 1.28 Mn |
| Jun 30, 2020 | 1.17 Mn |
| Mar 31, 2020 | 1.02 Mn |
| Dec 31, 2019 | 1.14 Mn |
| Sep 30, 2019 | 1.13 Mn |
| Jun 30, 2019 | 1.14 Mn |
| Mar 31, 2019 | 1.15 Mn |
| Dec 31, 2018 | 1.16 Mn |
| Sep 30, 2018 | 1.17 Mn |
| Jun 30, 2018 | 1.18 Mn |
| Mar 31, 2018 | 1.35 Mn |
| Dec 31, 2017 | 988,000.00 |